Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Millions	Jun. 30, 2025	Dec. 31, 2024
Assets
Amortized cost of fixed maturity securities valuation allowances	$ 151	$ 160
Amortized Cost	321,735	307,421
Mortgage loans valuation allowances	1,196	800
Real estate and real estate joint ventures - FVO	14,007	13,342
Real Estate Held-for-sale	152	65
Other Invested Assets - Leveraged and Direct Financing Leases	1,825	1,851
Other invested assets, at estimated fair value (2)	16,352	18,504
Premiums, reinsurance and other receivables relating to variable interest entities	31,503	29,761
Liabilities
Short-term Debt	379	465
Other liabilities (includes $41 and $0, respectively, relating to variable interest entities)	$ 39,074	$ 36,843
MetLife, Inc.’s stockholders’ equity:
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, Liquidation Preference, Value	$ 3,905	$ 3,905
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	3,000,000,000	3,000,000,000
Common stock, shares issued	1,195,301,071	1,194,168,628
Common stock, shares outstanding	666,827,962	689,211,065
Treasury stock, shares	528,473,109	504,957,563
Residential mortgage loans - FVO
Assets
Real estate and real estate joint ventures - FVO	$ 389	$ 378
Variable interest entities
Assets
Real estate and real estate joint ventures - FVO	210	183
Other invested assets, at estimated fair value (2)	523	424
Premiums, reinsurance and other receivables relating to variable interest entities	0	47
Liabilities
Short-term Debt	106	133
Other liabilities (includes $41 and $0, respectively, relating to variable interest entities)	$ 41	$ 0